Search

MSK’s Integrative Medicine Service focuses on empowering patients with practices — from acupuncture to music therapy — that fit seamlessly into your care plan.

… Thursday, April 10, 2025 A cancer diagnosis can make you feel as if the ground has shifted beneath you, throwing your life into a cycle of appointments, treatments, and scans. It’s common to feel waves of uncertainty or even disconnection from your own body.  MSK’s Integrative Medicine Service empowers

According to a large retrospective study co-led by Memorial Sloan Kettering Cancer Center and published in the Journal of Clinical Oncology, PTCy is an acceptable alternative to CNI-based prophylaxis in MUD HCT recipients and superior for MMUD HCT. These results will help improve minority donor participation in the NMDP registry.

… Wednesday, July 17, 2024 Post-transplantation cyclophosphamide (PTCy) led to similar overall survival (OS) and graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) in patients who received a hematopoietic stem cell transplant (HCT) from a matched unrelated donor (MUD) and those who received

In a recent interview, MSK's Dr. Jeffrey Drebin addressed why it’s important for people to keep up with their routine screenings and not put off cancer treatment or surgery.

… Wednesday, July 15, 2020 Cancer care is essential care and screenings and treatments can’t wait. That was the message that MSK’s Chair of the Department of Surgery, Jeffrey Drebin, MD, PhD , shared during a recent interview with Spectrum News NY1 .  Appearing via Skype with Roma Torre on the New York

Sloan Kettering Institute scientists are understanding more about natural killer (NK) cells, which are your allies when it comes to fighting infections and cancer.

… Tuesday, June 1, 2021 Despite a name straight from a Tarantino movie, natural killer (NK) cells are your allies when it comes to fighting infections and cancer. If T cells are like a team of specialist doctors in an emergency room, NK cells are the paramedics: They arrive first on the scene and perform

… Monday, April 6, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Charles L. Sawyers, MD, Awarded the Harrington Prize for Innovation in Medicine Charles L. Sawyers, MD Charles L. Sawyers, MD, Awarded the Harrington Prize for Innovation in Medicine

Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS) since 1987 in a variety of capacities. He formally assumes his new position as George J. Bosl, MD, steps down from his role after 18 years.

… Tuesday, November 17, 2015 Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS

Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s Paul Marks Prize for Cancer Research. The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant contributions to the understanding of cancer or are improving the treatment of the disease.

… Tuesday, November 4, 2025 Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s  Paul Marks Prize for Cancer Research . The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant

Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location, and its third on Long Island, will open for patient care on April 8 with more than 180 dedicated medical and professional staff, all of whom are MSK employees.

… Thursday, April 4, 2019 Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location

We love our smartphones, but could they be harming our health? An MSK expert weighs in.

… Monday, May 20, 2019 Summary A government-funded study published last year raised concerns about the dangers of cell phone radiation. An MSK radiation expert discusses the study’s limitations and weighs in on the evidence related to cell phone use and cancer risk. Back in 1993, a Florida resident named

Read about a new treatment for leptomeningeal metastasis that is giving patients hope.

… Wednesday, January 28, 2026 VIDEO | 03:35 Watch How Two MSK Labs Came Together to Give a Stage 4 Lung Cancer Patient More Time Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients